Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
Journal
The Lancet Diabetes and Endocrinology
Journal Volume
9
Journal Issue
8
Pages
491-501
Date Issued
2021
Author(s)
Subbiah V.
Hu M.I.
Wirth L.J.
Schuler M.
Mansfield A.S.
Curigliano G.
Brose M.S.
Zhu V.W.
Leboulleux S.
Bowles D.W.
Baik C.S.
Adkins D.
Keam B.
Matos I.
Garralda E.
Gainor J.F.
Lopes G.
Godbert Y.
Sarker D.
Miller S.G.
Clifford C.
Zhang H.
Turner C.D.
Taylor M.H.
SDGs
Publisher
Lancet Publishing Group
Type
journal article